CIK: 0002011385 · Show all filings
Period: Q4 2023 (Next →)
Filing Date: Feb 14, 2024
Total Value ($000): $106,674 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MLYS | Mineralys Therapeutics, Inc. | 9,194,579 | $79,073 | 74.1% | $7.85 | 0.0% | COM | 603170101 |
| — | HilleVax, Inc. | 1,308,974 | $21,009 | 19.7% | $16.05 | — | COM | 43157M102 |
| PHAT | Phathom Pharmaceuticals, Inc. | 721,962 | $6,592 | 6.2% | $8.62 | 0.0% | COM | 71722W107 |